Structure Therapeutics (NASDAQ:GPCR) Coverage Initiated at Citigroup
Citigroup began coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note released on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $60.00 price objective on the stock. GPCR has been the topic of a number of other research reports. HC Wainwright reaffirmed a “buy” rating and […]
Citigroup began coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note released on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $60.00 price objective on the stock. GPCR has been the topic of a number of other research reports. HC Wainwright reaffirmed a “buy” rating and […]
